Viatris“赢了”诺和诺德吗?! 司美格鲁肽专利战最新回合深度拆解 看这一篇就够了

Jo的随笔
26 Jul

(以下聚焦仅美国与加拿大)01最新战报:2025年7月24日究竟发生了什么?美国特拉华州地区法院作出即决判决,US 10,335,462(每周 1 mg 给药方案用途专利)被认定无效。该专利原本列在 FDA 橙皮书,保护期到 2033-06-21,是诺和诺德用来阻挡Wegovy仿制药上市的最后一道外围防线。该判决一出,多家自媒体迅速以“Viatris击败诺和诺德”刷屏,但,然并卵,其实人家...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10